XYZ Financial Statements & Analysis
Complete financial statements for XYZ including income statement, balance sheet, and cash flow statement. Analyze XYZ's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
83
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
10.1% ↑
Net Income
29546.4% ↑
Gross Margin
7.6% ↑
Operating Margin
390.8% ↑
Balance Sheet
Current Ratio
16.0% ↑
Debt to Equity
14.6% ↓
Asset Turnover
-1.1% ↓
Cash Flow
Operating Cash Flow
1591.1% ↑
Net Cash Flow
636.5% ↑
Free Cash Flow
3195.0% ↑
Cash Flow to Debt
1196.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 21.92B | 24.12B | 10.1% | |
| Gross Profit | 7.50B | 8.89B | 18.4% | |
| Operating Income | -278839000 | 892.33M | 420.0% | |
| Net Income | 9.77M | 2.90B | 29546.4% | |
| EPS | 0.016 | 4.7 | 29275.0% | |
| EBITDA | 390.53M | 1.35B | 244.6% | |
| Gross Margin | 34.24% | 36.85% | 7.6% | |
| Operating Margin | -1.27% | 3.70% | 390.8% | |
| Net Income Margin | 0.04% | 12.01% | 26835.8% | |
| R&D Expenses | 2.72B | 2.91B | 7.1% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 24.12B | 21.92B | 17.53B | 17.66B | 9.50B |
| Gross Profit | 8.89B | 7.50B | 5.99B | 4.42B | 2.73B |
| Operating Income | 892.33M | -278839000 | -624532000 | 161.11M | 272.91M |
| Net Income | 2.90B | 9.77M | -540747000 | 166.28M | 213.10M |
| EPS | 4.7 | 0.016 | -0.93 | 0.36 | 0.48 |
| EBITDA | 1.35B | 390.53M | -58755000 | 408.48M | 427.38M |
| Gross Margin | 36.85% | 34.24% | 34.18% | 25.03% | 28.78% |
| Operating Margin | 3.70% | -1.27% | -3.56% | 0.91% | 2.87% |
| Net Income Margin | 12.01% | 0.04% | -3.08% | 0.94% | 2.24% |
| R&D Expenses | 2.91B | 2.72B | 2.14B | 1.40B | 881.83M |